Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30043920HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30043921HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30043922HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS20029321HPVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS20020564HPVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS20020565HPVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS20020566HPVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS44023858HTLV-1ENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS44051353HTLV-1ENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS44049651HTLV-1ENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TCGA Plot Options
Drug Information
GeneSTAT3
DrugBank IDDB16630
Drug NameOPB-111077
Target IDBE0003462
UniProt IDP40763
Regulation Typeinhibitor
PubMed IDs29511132
CitationsTolcher A, Flaherty K, Shapiro GI, Berlin J, Witzig T, Habermann T, Bullock A, Rock E, Elekes A, Lin C, Kostic D, Ohi N, Rasco D, Papadopoulos KP, Patnaik A, Smith L, Cote GM: A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers. Oncologist. 2018 Jun;23(6):658-e72. doi: 10.1634/theoncologist.2017-0325. Epub 2018 Mar 6.
GroupsInvestigational
Direct Classification
SMILES
Pathways
PharmGKB
ChEMBL